¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"RNA, transfer, met"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • frontalis transfer
    À̸¶±Ù¿Å±è(¼ú), ÀüµÎ±ÙÀüÀÌ(¼ú)
  • gene transfer
    À¯ÀüÀÚÀü´Þ
  • gene transfer therapy
    À¯ÀüÀÚÀ̽Ŀä¹ý
  • gamete intrafallopian transfer
    »ý½Ä¼¼Æ÷Àڱðü³»À̽Ä, »ý½Ä¼¼Æ÷Àڱðü³»Àü´Þ
  • heat transfer rate
    ¿­Àü´Þ·ü
  • magnetization transfer technique
    ÀÚ¼ºÈ­Àü´Þ±â¼ú
  • mass energy transfer coefficient
    Áú·®¿¡³ÊÁöÀüÀ̰è¼ö
  • magnetic transfer contrast
    ÀÚ±âÈ­Àü´Þ´ëÁ¶µµ
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • magnetization transfer pulse
    ÀÚ±âÈ­Àü´ÞÆÄ
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
  • passive transfer
    ¼öµ¿Àü´Þ
  • resistance transfer factor
    ³»¼ºÀü´ÞÀÎÀÚ
  • tendon transfer
    ÈûÁÙÀüÀÌ(¼ú), °ÇÀüÀÌ(¼ú)
  • zygote intrafallopian transfer
    Á¢ÇÕÀÚÀڱðü³»À̽Ä, Á¢ÇÕüÀڱðü³»Àü´Þ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • magnetisation transfer coherence
    ÀÚ±âÈ­Àü´Þ°áÁý
  • mass energy transfer coefficient
    Áú·®¿¡³ÊÁöÀüÀ̰è¼ö
  • direct transfer flap
    Á÷Á¢ÇÇÆÇ
  • electro transfer system
    ÀüÀÚÀü´Þ°è, ÀüÀÚ¿î¹Ýü
  • magnetization transfer effect
    ÀÚ±âÈ­Àü´ÞÈ¿°ú
  • fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀ̸鿪ºÐ¼®(¹ý), Çü±¤µé¶äÀüÀ̸鿪ºÐ¼®(¹ý)
  • free flap transfer
    À¯¸®ÇÇÆÇÀüÀÌ, À¯¸®ÇÇÆÇÀüÀ̼ú
  • frontalis transfer
    À̸¶±Ù¿Å±è¼ú, ÀüµÎ±ÙÀüÀ̼ú
  • transfer factor
    Àü´ÞÀÎÀÚ
  • transfer forceps
    Àü´ÞÁý°Ô, À̵¿°âÀÚ, Àü´Þ°âÀÚ
  • gene transfer
    À¯ÀüÀÚÀü´Þ
  • heat transfer rate
    ¿­Àü´Þ·ü
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • linear energy transfer radiation
    ¼±»ó¿¡³ÊÁöÀüȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • placental transfer
    ŹÝÀ̵¿(÷ÃÚïì¹ÔÑ)
  • radiation,linear energy transfer (let)
    ¼±»ó¿¡³ÊÁöÀüȯ(àÊß¾¡­ï®üµ)
  • DNA polymerase, RNA dependent
    RNA- ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA polymerase, RNA-dependent
    RNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-RNA hybridization
    DNA-RNA ¦Áö¿ì±â, DNA-RNA ºÎÇÕ°Ë»ç¹ý(ݬùê~)
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ RNA ÁßÇÕÈ¿¼Ò
  • RNA =>ribonucleic acid
    ¸®º¸ÇÙ»ê
  • RNA editing
    RNA ±³Á¤
  • RNA polymerase
    RNA ÁßÇÕÈ¿¼Ò
  • RNA polymerase I
    RNA ÁßÇÕÈ¿¼Ò I
  • RNA recombination
    RNA Àç°áÇÕ
  • RNA splicing
    RNA ½ºÇöóÀ̽Ì, RNA Àç´Ü, RNA Â¥±é±â
  • RNA virus
    RNA¹ÙÀÌ·¯½º.
  • RNA virus
    RNA ¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • positive strand RNA
    ¾ç¼º°¡´Ú RNA
  • pseudoknot RNA structure
    ¸ÅµìÇü RNA ±¸Á¶
  • ribonucleic acid =RNA
    ¸®º¸ÇÙ»ê (¡­ú·ß«).
  • ribosomal RNA
    ¸®º¸¼Ø¸®º¸ÇÙ»ê(¡­ú·ß«).
  • rna oncogenic virus
    RNA(¸®º¸ÇÙ»ê)¹ß¾Ï¼º ¹ÙÀÌ·¯½º(Û¡äßàõ¡­)
  • subgenomic RNA
    ¾ÆÁö³ð RNA
  • subgenomic m-RNA
    ¾ÆÁö³ð mRNA
  • adoptive transfer
    ÀÎÀÔ(¸é¿ª)Àü´Þ(ìÚìýØóæ¹îîÓ¹).
  • adoptive transfer
    ÀÔ¾çÀü´Þ
  • afterimage transfer test
    ÀÜ»óÀüÀ̰˻ç
  • antibody transfer
    Ç×üÀÌÀÔ(¡­ì¹ìý).
  • conjugal transfer
    Á¢ÇÕÀü´Þ
  • drug resistance transfer factor
    ¾àÁ¦³»¼ºÀü´ÞÀÎÀÚ
  • electron transfer
    ÀüÀÚÀ̵¿(¡­ì¹ÔÑ), ÀüÀÚ¿î¹Ýü(¡­ê¡Úæô÷).
  • electron transfer system
    ÀüÀÚ¿î¹Ýü.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • assimilation transfer
    µ¿È­¼ºÀÌÀü (ÔÒûùàõì¹ï®)
  • asymmetric strand transfer model
    ºñ´ëĪ(ÞªÓßöà) °¡´ÚÀüÀÌ(ï®ì¹) ¸ðµ¨
  • charge transfer complex
    ÀüÇÏÀ̵¿ º¹ÇÕü(ï³ùÃì¹ÔÑÜÜùêô÷)
  • charge transfer relay system
    ÀüÇÏÀ̵¿(ï³ùÃì¹ÔÑ) ¸±·¹ÀÌ ¾¾½ºÅÛ
  • cholesterol ester transfer protein
    ÄÝ·¹½ºÅ×·Ñ¿¡½ºÅÍ ÀüÀ̴ܹéÁú(ï®ì¹Ó±ÛÜòõ)
  • electron transfer chain
    ÀüÀÚÀü´Þ(ï³í­îîÓ¹) »ç½½
  • electron transfer flavoprotein
    ÀüÀÚÀü´Þ(ï³í­îîÓ¹) Ç÷¹À̺¸´Ü¹éÁú(Ó±ÛÜòõ)
  • electron transfer potential
    ÀüÀÚÀü´Þ ÀüÀ§(ï³í­îîÓ¹ï³êÈ)
  • electron transfer protein
    ÀüÀÚÀü´Þ ´Ü¹éÁú(ï³í­îîÓ¹Ó±ÛÜòõ)
  • electron transfer system
    ÀüÀÚÀü´Þ(ï³í­îîÓ¹) ½Ã½ºÅÛ
  • energy transfer
    ¿¡³ÊÁö ÀüÀÌ(ï®ì¹)
  • exciton transfer
    ¿¢½ÃÅæ ÀüÀÌ(ï®ì¹)
  • filter affinity transfer
    °Å¸£°Ô ģȭÀüÀÌ(öÑûúï®ì¹)
  • group transfer reaction
    ¿øÀÚ´Ü ÀüÀÌ ¹ÝÀÀ(ê«í­Ó¥ï®ì¹Úãëë)
  • group transfer potential
    ¿øÀÚ´Ü ÀüÀÌ ÀüÀ§(ê«í­Ó¥ï®ì¹Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
U-RNA uridylic acid ribonucleic acid
MTP maximum tolerated pressure; medial tibial plateau; median time to progression; metacarpophalangeal; ...
Met. Metabilic; ´ë»ç¼º
F-met, fMet formyl methionine
MET maximal exercise test; metabolic equivalent of the task; metastasis, metastatic; methionine; midexpi...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
poly(A)+ RNA Polyadenylated RNA
RDRP RNA dependent RNA polymerase
sat RNA satellite RNA
tRNA Transfer RNA
n-RNA nuclear RNA
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • transcapillary transfer
    ¸ð¼¼°ü À̵¿
  • transfer
    Àü´Þ, ÀüÀÌ, Àü¼ÛÇÏ´Ù
    ÇÑ Àå¼Ò¿¡¼­ ´Ù¸¥ Àå¼Ò·Î ¾î¶² ¹°ÁúÀÌ À̵¿µÇ´Â °Í.
  • transfer coping
    ±Ý¼ÓÁ¦ °ñ¹«, Áö´ëÄ¡ ¸ðÇü °íÁ¤¿ë °ñ¹«, ÀüÀÌ¿ë ÄÚÇÎ
    ÀÎ»ó¿¡ Ä¡ÇüÀ» À§Ä¡½Ã۴µ¥ »ç¿ëÇÏ´Â ±Ý¼Ó ¶Ç´Â ¾ÆÅ©¸± ¼öÁö·Î µÈ ÇǺ¹¹°À̳ª ca
  • transfer factor
    Àü´Þ ÀÎÀÚ, ÀüÀÌ ¿äÀÎ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
RNA, transfer, phe A transfer RNA which is specific for carrying phenylalanine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, pro A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, ser A transfer RNA which is specific for carrying serine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, thr A transfer RNA which is specific for carrying threonine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, trp A transfer RNA which is specific for carrying tryptophan to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, tyr A transfer RNA which is specific for carrying tyrosine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
RNA, transfer, val A transfer RNA which is specific for carrying valine to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
transfer RNA <molecular biology> A nucleic acid found in all living cells. Plays a role in transferring information from DNA to the protein-forming system of the cell.
(16 Dec 1997)
met 1. <oncogene> An oncogene, identified in mouse osteosarcoma.
2. <chemistry> Having less than the highest number of hydroxyl groups; said of acids; as, metaphosphoric acid. Also used adjectively.
(04 Mar 1998)
met enkephalin <protein> See enkephalins.
(18 Nov 1997)
Met-enkephalin heptapeptide dipeptidase <enzyme> Enzyme from rabbit ear artery forms met-enkephalin from met(5)-enkephalin-arg(6)-phe(7); inhibited by captopril
Registry number: EC 3.4.15.-
Synonym: met-enkephalin-arg(6)-phe(7) cleavage enzyme, me-ap dipeptidase
(26 Jun 1999)
met repressor operator complex Repressor protein, 104 residues, product of the metJ gene, which regulates methionine biosynthesis in E. Coli. Dimeric molecules bind to adjacent sites 8 base pairs apart on the DNA, sequence recognition is by interaction between antiparallel strands of protein and the major groove of the B form DNA duplex.
(18 Nov 1997)
proto-oncogene proteins c-met <enzyme> A transmembrane tyrosine kinase that is the receptor for hepatocyte growth factor (scatter factor). It consists of an extracellular alpha chain which is disulfide linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and critical sites for the regulation of kinase activity.
Registry number: EC 2.7.11.-
(12 Dec 1998)
adoptive transfer Form of passive immunization where previously sensitised immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (immunotherapy, adoptive).
(12 Dec 1998)
gamete intra-fallopian transfer <gynaecology> Gamete intra-fallopian transfer is a technique that involves combining eggs and sperm outside of the body and immediately placing them into the fallopian tubes to achieve fertilization.
A technique that came into use in the mid-1980's for assisted conception in infertile women with normal fallopian tubes. The protocol consists of hormonal stimulation of the ovaries, followed by laparoscopic follicular aspiration of oocytes, and then the transfer of sperm and oocytes by catheterization into the fallopian tubes.
Acronym: GIFT
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • egg transfer baby
    (ÀÇ)¼öÁ¤¶õ À̽ľÆ
  • electronic funds transfer
    ÀüÀÚ½Ä ÀÚ±Ý ÀÌü(ÀÌÇà °áÁ¦)
  • electronic transfer
    ÀüÀÚ½Ä ±ÝÀü Ãâ³³
  • embryo transfer
    (ÀÇ)¹èÀ̽Ä(Àڱà ³»ÀÇ Å¾Ƹ¦ ¿Ü°úÀû ¼ö´ÜÀ¸·Î ´Ù¸¥ ÀÚ±ÃÀ¸·Î ¿Å±â´Â °Í)
  • negative transfer
    ¼Ò±ØÀû ÀüÀÌ(ÇнÀ °úÁ¤¿¡¼­ ¼±Çà ÇнÀÀÌ ÈÄÀÇ ÇнÀÀ» ¹æÇØ ¾ïÁ¦
  • transfer
    Àüȯ;À̵¿;ÀüÇÐ;ÀüÀÓ;(±Ç¸®ÀÇ)ÀÌÀü;(¸íÀÇÀÇ)º¯°æ;´ëü;ȯ;°¥¾ÆÅ¸±â;°¥¾ÆÅ¸´Â Ç¥
  • transfer
    ¿Å´Ù;ÀüÀԵǴÙ;°¥¾ÆÅ¸´Ù
  • transfer
    ¿Å±â´Ù;³ª¸£´Ù;¾çµµÇÏ´Ù;Àü»çÇÏ´Ù;ÀüÀÓ½ÃŰ´Ù
  • transfer company
    ±Ù°Å¸® ¿î¼Ûȸ»ç(µÎ Å͹̳Π¿ª ±¸°£ µî)
  • transfer table
    (Áö»ó½Ä)õÂ÷´ë
  • transfer tax
    »ó¼Ó¼¼;¾çµµ¼¼
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á